HK Stock Market Move | INNOGEN-B (02591) fell by over 9% today after closing up by over 32% yesterday. Cornerstone investors will face a lifting of restrictions this week.

date
15:48 12/05/2026
avatar
GMT Eight
Yinuo Pharmaceuticals-B (02591) fell more than 9%, after rising over 32% yesterday. As of the time of writing, it is down 9.1% to HK$15.18, with a turnover of HK$131 million.
INNOGEN-B (02591) fell more than 9%, after rising over 32% yesterday. As of press time, it fell 9.1% to HK$15.18, with a turnover of HK$131 million. On the news side, according to a previous announcement by Yinnuo Medicine, the lock-up period for cornerstone investors will expire on May 14, 2026, and the related shares will be officially unlocked for circulation on May 15. The cornerstone investors hold a total of 4.21 million shares. Yinnuo Medicine's performance in 2025 showed that the group generated revenue of approximately 131.5 million yuan, mainly from the sale of Yisupageru peptide in China. The net loss was 341 million yuan, a year-on-year increase of 95.4%.